Selective inhibitors of plasma kallikrein

Immunopharmacology

Volumn 32, Issue 1-3, 1996, Pages 115-116

  Evans, D Michael ^a   Jones, D Michael ^a   Pitt, Gary R ^a   Sueiras Diaz, Javier ^a   Horton, John ^a   Ashworth, Doreen ^a   Olsson, Håkan ^b   Szelke, Michael ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b Ferring AB   (Sweden)

Author keywords

Enzyme inhibitor; High molecular kininogen; Plasma kallikrein

Indexed keywords

KALLIKREIN; KALLIKREIN INHIBITOR; PLASMIN; SERINE PROTEINASE INHIBITOR; SYNTHETIC PEPTIDE; THROMBIN;

CONFERENCE PAPER; ENZYME INHIBITION; HUMAN; PRIORITY JOURNAL;

EID: 0343150925     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/0162-3109(95)00068-2     Document Type: Conference Paper

References (4)

1. Bhoola KD, Figueroa CD, Worthy K. Bioregulation of kinins: kallikreins, kininogens and Kininases. Pharmacol. Rev. 1992; 44: 1-80.
2. Fujimora Y, Nakamura T, Shimizu K, Yamamuro T, Wanaka K, Okamoto S, Katsuura Y. Effects of a highly selective plasma kallikrein inhibitor on collagen-induced arthritis in mice. Agents Actions 1993; 39: 42-48.
3. Okamoto S, Wanaka K, Hijikata-Okunomiya A, Okada Y, Katsuura Y. A finding of highly selective synthetic inhibitor of plasma kallikrein; its action to bradykinin generation, intrinsic coagulation and experimental DIC. In: Fritz H, Müller-Esterl W, Jochum M, Roscher A, Lappertz K, Eds. AAS 38/I. Recent Progress on Kinins. Basel: Birkhäuser Verlag 1992, 198-205.
4. Szelke M, Evans DM, Jones DM (1990) Patent: WO 92/04371. (GB priority date 07.09.90).